Figure 1.
(A) The distribution of tumor purity in three datasets. (B) The distribution of tumor purity among TNM stages, MMR status, and primary locations in microarray dataset. (C) The distribution of tumor purity among TNM stages, MMR status, and primary locations in TCGA dataset. (D) Kaplan–Meier analysis of overall survival showed low purity colon cancer (separated by X-tile) that conferred worse prognosis in microarray dataset.
Notes: ***P<0.001, **P=0.008.
Abbreviations: TNM, tumor node metastasis; MMR, DNA mismatch repair; dMMR, MMR-deficient; pMMR, MMR-proficient.